Iterum Therapeutics Revenue

Iterum Therapeutics had revenue of $390.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $390.00K.

Revenue (ttm)

390.00K

Revenue Growth

n/a

P/S Ratio

6.76

Revenue / Employee

43.33K

Employees

Market Cap

2.64M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
GEO JS Tech Group	5.83M
BOL Bancshares	5.67M
Carroll Shelby International	4.44M
hopTo	4.19M
AI Maverick Intel	92.26K
Life's Time Capsule Services	13.79K
Peer to Peer Network	131.00

Revenue Rankings

Iterum Therapeutics News

6 days ago - Iterum files wind-up petition due to limited cash, inability to raise equity - Reuters
6 days ago - Iterum Therapeutics Announces Filing of Winding Up Petition - GlobeNewsWire
6 weeks ago - Iterum Therapeutics Provides Business Update - GlobeNewsWire
4 months ago - Iterum Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
5 months ago - Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025 - GlobeNewsWire
6 months ago - Iterum Therapeutics to Present Data at IDWeek 2025 - GlobeNewsWire
8 months ago - Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S. - GlobeNewsWire
8 months ago - Iterum Therapeutics Reports Second Quarter 2025 Financial Results - GlobeNewsWire

More News